Vectron Biosolutions, a NTNU start-up in Trondheim, has unique, next-generation, proprietary production technologies that greatly reduce the cost-of-goods in protein manufacture. The global market value for recombinant proteins exceeds USD 164 billion and grows with an AAGR of 5-10 %.

Vectron’s patented technologies are validated by the market through existing license agreements with companies in selected segments.